Weekly channel feed – Endpoints News

SIGN UP

Weekly channel feed

The Endpoints 20 under 40, biotech's new normal, Stéphane Bancel's one regret, and more

6 days ago

Legendary biotech leader passes away, renewed tension around aducanumab, Merck's rare defeat, and more

Last week

AstraZeneca's Covid-19 vaccine woes, Moncef Slaoui resigns over sexual harassment claims, FDA acts tough, and more

3 weeks ago

Merck's C-suite shakeup, Eli Lilly stirs fresh Alzheimer's controvery, play by play of Amgen's $2B buyout, and more

4 weeks ago

Novartis' wild card blockbuster contender falls flat; Regulatory reckoning for checkpoint drugs looms; and more

Last month

The top 100 biopharma VCs, Bob Bradway places $2B bet in cancer, gene editing pioneer's new big idea, and more

Last month

The future of mRNA, J&J's vaccine adcomm, Merck's $1.85B autoimmune bet and more

Last month

A gene therapy leader stumbles, Medicxi's splashy 10-in-1 startup play, a radical HIV cure gets its shot, and biopharma's new top 50

Last month

All of the news, delivered with full-text to your inbox. For professionals discovering, developing, and marketing biopharmaceutical drugs.

SIGN UP NOW

Subscribe to Endpoints News